Dr. Reddy's Laboratories Limited Stock price NSE India S.E.

Equities

DRREDDY

INE089A01023

Pharmaceuticals

Delayed NSE India S.E. 02:34:23 2024-03-19 am EDT 5-day change 1st Jan Change
6,212 INR -2.03% Intraday chart for Dr. Reddy's Laboratories Limited -1.54% +7.02%
Sales 2024 * 278B 3.36B Sales 2025 * 298B 3.59B Capitalization 1,056B 12.73B
Net income 2024 * 54.46B 657M Net income 2025 * 56.36B 680M EV / Sales 2024 * 3.53 x
Net cash position 2024 * 72.87B 879M Net cash position 2025 * 112B 1.35B EV / Sales 2025 * 3.17 x
P/E ratio 2024 *
19.4 x
P/E ratio 2025 *
18.7 x
Employees 25,863
Yield 2024 *
0.64%
Yield 2025 *
0.66%
Free-Float 91.47%
More Fundamentals * Assessed data
Dynamic Chart
Asian Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher in Monday Trading MT
Asian Equities Traded in the US as American Depositary Receipts End Week Lower in Friday Trading MT
Dr. Reddy's Laboratories Limited Approves Incorporation of A Wholly-Owned Subsidiary of the Company CI
Asian Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading MT
Dr. Reddy's Laboratories Limited Receives an Order from GST Authority Towards Tax Demand Including Interest and Carbon CI
Asian Equities Traded in the US as American Depositary Receipts Rally in Tuesday Trading MT
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading MT
Asian Equities Traded in the US as American Depositary Receipts Surge Higher in Friday Trading, Led by Tech, Bank Stocks MT
Upbeat Global Markets, Strong GDP Send Indian Equities to Record Closing High on Friday MT
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading MT
Bank, Auto Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Lower Wednesday MT
Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading MT
Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading MT
Asian Equities Traded in the US as American Depositary Receipts Flat in Friday Trading MT
India pharma companies develop versions of Wegovy to get in on weight-loss windfall RE
More news

Latest transcript on Dr. Reddy's Laboratories Limited

1 day-2.12%
1 week-1.52%
Current month-3.39%
1 month-3.28%
3 months+10.09%
6 months+10.53%
Current year+7.05%
More quotes
1 week
6 192.80
Extreme 6192.8
6 354.90
1 month
6 172.10
Extreme 6172.1
6 505.90
Current year
5 520.65
Extreme 5520.65
6 505.90
1 year
4 384.05
Extreme 4384.05
6 505.90
3 years
3 654.00
Extreme 3654
6 505.90
5 years
2 351.20
Extreme 2351.2
6 505.90
10 years
1 872.95
Extreme 1872.95
6 505.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 18-04-01
Director of Finance/CFO - 20-11-01
Chairman 56 93-01-17
Members of the board TitleAgeSince
Chairman 63 86-04-07
Chairman 56 93-01-17
Director/Board Member 73 07-06-04
More insiders
Date Price Change Volume
24-03-19 6,212 -2.03% 110 732
24-03-18 6,341 +0.89% 180,493
24-03-15 6,285 -0.15% 485,947
24-03-14 6,295 -0.15% 400,212
24-03-13 6,304 +0.03% 210,265

Delayed Quote NSE India S.E., March 19, 2024 at 02:01 am EDT

More quotes
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows: - sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines; - sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services; - other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc. Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
36
Last Close Price
6,340 INR
Average target price
5,978 INR
Spread / Average Target
-5.72%
Consensus
  1. Stock
  2. Equities
  3. Stock Dr. Reddy's Laboratories Limited
  4. Stock Dr. Reddy's Laboratories Limited - NSE India S.E.